McMinn Rachel 4
4 · Neurogene Inc. · Filed Mar 28, 2025
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
McMinn Rachel
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-03-26+23,900→ 1,274,259 total - Award
Employee Stock Option (Right to buy)
2025-03-26+143,500→ 143,500 totalExercise: $16.14From: 2025-03-26→ Common Stock (143,500 underlying)
Footnotes (2)
- [F1]Consist of 23,900 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date.
- [F2]This option represents the right to purchase 143,500 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.